Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2023 call → NOWe need to determine if management describes the company as currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event that ends the wait, and that this is the main current work. Let's analyze the transcript. The company is NICE Ltd. They discuss results, AI, cloud growth, etc. They mention the acquisition of LiveVox. They say: "We successfully completed the acquisition of LiveVox near the end of December 2023." They also say: "We expect LiveVox to contribute approximately $142 million to total revenue, which will be attributed to our cloud revenue line from the start of 2024. We assume some revenue redundancy in the initial year of transition and expect this acquisition to show growth in 2025 and beyond." So they are integrating LiveVox. They mention "initial year of transition" and "revenue redundancy" - meaning they are paying for something (the acquisition) but not yet getting full benefit? Actually, they say LiveVox will contribute $142 million to total revenue in 2024, so it is already contributing. But they mention "revenue redundancy" - perhaps meaning some revenue is lost due to transition? They expect growth in 2025 and beyond. So the waiting period is the initial year of transition, and the benefit (growth) will come in 2025. But is that a defined waiting period? They say "initial year of transition" - that is a specific period. They are paying for it (the acquisition cost, integration costs) and the benefit (growth) will come later. But is this the main current work? They talk about integration: "We are now, as I said, about two months into this execution. And I would say that, first of all, from integrating the two organization that's behind us, you can also see it in the great profitability that we have guided to this year, not only from LiveVox, but obviously, they are accretive to that as well." So they are integrating, but they also say it's accretive. So they are already getting some benefit. The waiting period is for full growth? They say "expect this acquisition to show growth in 2025 and beyond." So the far side is 2025, which is within about a year? Actually, 2025 is about 10 months away from the call (Feb 2024). So that is near-dated.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.